Bilaketaren emaitzak - Kunhwa Kim
- Erakusten 1 - 6 emaitzak -- 6
-
1
Venetoclax resistance: mechanistic insights and future strategies nork Faustine Ong, Kunhwa Kim, Marina Konopleva
Argitaratua 2022Revisão -
2
Nonstereotyped Lymphoma B Cell Receptors Recognize Vimentin as a Shared Autoantigen nork Soung-Chul Cha, Hong Qin, Shibichakravarthy Kannan, Seema Rawal, Leticia S. Watkins, Flavio E. Baio, Weiguo Wu, Juliana Ong, Jinsong Wei, Benjamin Kwak, Sang Kim, Michael Popescu, Daniel S. Paick, Kunhwa Kim, Amber Luong, R. Eric Davis, Harry W. Schroeder, Larry W. Kwak, Sattva S. Neelapu
Argitaratua 2013Artigo -
3
Outcomes of <i>TP53</i>‐mutant acute myeloid leukemia with decitabine and venetoclax nork Kunhwa Kim, Abhishek Maiti, Sanam Loghavi, Rasoul Pourebrahim, Tapan M. Kadia, Caitlin R. Rausch, Ken Furudate, Naval Daver, Yesid Alvarado, Maro Ohanian, Koji Sasaki, Nicholas J. Short, Koichi Takahashi, Musa Yılmaz, Guilin Tang, Farhad Ravandi, Hagop M. Kantarjian, Courtney D. DiNardo, Marina Konopleva
Argitaratua 2021Artigo -
4
Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate Cancer nork Michael C. Haffner, Güneş Güner, Diana Taheri, George J. Netto, Doreen N. Palsgrove, Qizhi Zheng, Liana B. Guedes, Kunhwa Kim, Harrison Tsai, David Esopi, Tamara L. Lotan, Rajni Sharma, Alan K. Meeker, Arul M. Chinnaiyan, William G. Nelson, Srinivasan Yegnasubramanian, Jun Luo, Rohit Mehra, Emmanuel S. Antonarakis, Charles G. Drake, Angelo M. De Marzo
Argitaratua 2018Artigo -
5
AIM1 is an actin-binding protein that suppresses cell migration and micrometastatic dissemination nork Michael C. Haffner, David Esopi, Alcides Chaux, Meltem Ö. Gürel, Susmita Ghosh, Ajay Vaghasia, Harrison Tsai, Kunhwa Kim, Nicole Castagna, Hong Lam, Jessica Hicks, Nicolas Wyhs, Debika Biswal Shinohara, Paula J. Hurley, Brian W. Simons, Edward M. Schaeffer, Tamara L. Lotan, William B. Isaacs, George J. Netto, Angelo M. De Marzo, William G. Nelson, Steven S. An, Srinivasan Yegnasubramanian
Argitaratua 2017Artigo -
6
Phase II study of azacitidine with pembrolizumab in patients with intermediate‐1 or higher‐risk myelodysplastic syndrome nork Kelly S. Chien, Kunhwa Kim, Graciela M. Nogueras‐González, Gautam Borthakur, Kiran Naqvi, Naval Daver, Guillermo Montalban‐Bravo, Jorge E. Cortés, Courtney D. DiNardo, Elias Jabbour, Yesid Alvarado, Michael Andreeff, Prithviraj Bose, Nitin Jain, Tapan M. Kadia, Xuelin Huang, Kimberly Sheppard, Cheri Klingner‐Winton, Sherry Pierce, Xiao Qin Dong, Kelly A. Soltysiak, Hagop M. Kantarjian, Guillermo Garcia‐Manero
Argitaratua 2021Artigo
Bilaketa egiteko lanabesak:
Antzeko gaiak
Biology
Genetics
Cancer research
Medicine
Cancer
Immunology
Internal medicine
Oncology
Azacitidine
Cell
Chronic lymphocytic leukemia
Cytoskeleton
DNA methylation
Gene
Gene expression
Immunohistochemistry
Immunotherapy
Leukemia
Myeloid leukemia
Prostate
Prostate cancer
Venetoclax
Actin
Actin cytoskeleton
Actin-binding protein
Adenocarcinoma
Antibody
Apoptosis
Biochemistry
Bioinformatics